USFDA completes inspection of Natco facility

Our Bureau Hyderabad | Updated on March 08, 2020

Natco Pharma Ltd has announced the completion of a pre-approval inspection from the United States Food and Drug Administration (USFDA) for its formulation facility in Kothur Village, near Hyderabad. The inspection was conducted from March 2 to 6.

At the end of the inspection, the facility received a single observation related to equipment qualification of a co-mill used in the process that had operating speed slightly outside the qualification range. The company believes that this is a minor observation and can be addressed soon.

The company will provide justification and corrective action plan within the next 15 working days to address this observation, Natco informed in a statement.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on March 08, 2020
This article is closed for comments.
Please Email the Editor